CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 7, 2024 · earnings

CRVS earnings: a negative outcome, -12.0%

On May 7, 2024, Corvus Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -12.0% in the window around the event. It had already run +9.7% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.91
1d before
$1.68
Event day
$1.96
1d after
$2.08
5d after

Pre-catalyst setup

+9.7%
30-day run-up
7932%
30-day volatility
5.2×
volume spike